Don't Dismiss Heartburn as "Just Another Thing" — Understanding the "125 Times Cancer Risk" Correctly

Don't Dismiss Heartburn as "Just Another Thing" — Understanding the "125 Times Cancer Risk" Correctly

After meals, a burning sensation occurs deep in the chest. Sourness rises up to the throat. Coughing occurs at night. Since these symptoms are not uncommon, many people tend to think, "I overate," "It's due to age," or "Over-the-counter medicine will cure it."

However, an article published by the German newspaper WELT on September 18, 2026, conveyed in strong words the changes that follow heartburn. When stomach acid repeatedly refluxes into the esophagus, the mucosa is damaged and eventually replaced by a different type of cell to protect itself. In this state, the risk of esophageal cancer can increase up to 125 times.

"Heartburn makes cancer 125 times more likely." Linking only these two points would make anyone anxious. However, misreading the numbers can create unnecessary fear while obscuring what those who truly need to seek medical attention should be wary of.

In conclusion, not everyone who experiences heartburn has a 125-fold increase in cancer risk. The "125 times" figure is derived from a high relative risk estimate comparing a subset of people with Barrett's esophagus, a mucosal change due to long-term reflux, to the general population. Moreover, current large-scale studies and guidelines suggest that the absolute risk of progressing from Barrett's esophagus without dysplasia to esophageal adenocarcinoma is not as high as once feared.

However, this does not mean that heartburn should be taken lightly. What is needed is to break down the provocative number "125 times" into the stages of disease progression and actual probability to understand it.


The esophagus is not resistant to stomach acid

The esophagus is a tube that carries food from the mouth to the stomach. The stomach is equipped with defense mechanisms to handle strong acid, but the squamous epithelium lining the esophagus is not designed to be repeatedly exposed to stomach acid.

Normally, the lower esophageal sphincter and diaphragm at the junction of the esophagus and stomach prevent reflux. However, if this mechanism weakens or relaxes at inappropriate times, the contents of the stomach can return to the esophagus. Repeated reflux that interferes with daily life or causes inflammation of the esophagus is known as gastroesophageal reflux disease, or GERD.

Typical symptoms include heartburn and acid regurgitation, but they can also manifest as chest pain, nausea, difficulty swallowing, chronic cough, or hoarseness. What is more troublesome is that reflux can occur and mucosal changes can progress even in people who do not feel obvious heartburn. This is why it is called "silent reflux."


The "protective layer" is the esophagus's transformation to survive

When reflux persists for a long time, the lower part of the esophagus may see its original squamous epithelium replaced by columnar epithelium similar to the mucosa of the stomach or intestines. This is Barrett's esophagus.

What the WELT article refers to as "first a protective layer is formed" technically refers to "metaplasia," where the type of cell itself changes rather than a new membrane covering from above. The new cells are relatively resistant to acid and digestive juices, considered a result of the body's adaptation to chronic irritation.

At first glance, it seems like a smart defensive reaction. However, tissue where cells have been replaced in an atypical form can accumulate genetic abnormalities over many years, leading to dysplasia and eventually esophageal adenocarcinoma. In other words, Barrett's esophagus is not cancer itself but can be a foundation where cancer is more likely to develop.

However, there is a very important fact here. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) states that the majority of people with Barrett's esophagus do not develop esophageal cancer. The risk varies significantly depending on the length of Barrett's esophagus, age, gender, smoking, abdominal obesity, family history, and whether dysplasia is present in a biopsy.


What does the "125 times" figure compare?

When a "multiple" figure appears in medical information, three things need to be confirmed: who is being compared to whom, what disease is being counted, and what the original probability is.

The expression "30 to 125 times" has been used in past medical literature and textbooks to compare the risk of esophageal adenocarcinoma in Barrett's esophagus, particularly long-segment Barrett's esophagus where the altered mucosa extends over 3 centimeters, with the general population. Since esophageal adenocarcinoma is originally rare in the general population, the relative risk tends to be a large number.

For example, if the incidence increases from 1 to 10 per 100,000 people, the relative risk is 10 times, but the absolute increase is 9 per 100,000 people. "Multiple" and "how many people develop" are not the same information.

A large-scale Danish study reported that the incidence of esophageal adenocarcinoma among people with Barrett's esophagus is about 1.2 per 1,000 people per year, and about 1.0 per 1,000 people if limited to those without dysplasia. The numbers vary depending on the target population and diagnostic criteria, but it is clear that the understanding that "if you have Barrett's esophagus, you will likely develop cancer" is incorrect.

On the other hand, if low-grade or high-grade dysplasia is confirmed, the situation changes. The higher the degree of cellular abnormality, the higher the risk of progression, and treatment such as endoscopic resection or ablation is considered, not just surveillance. The important thing is that the presence or absence of heartburn alone cannot determine this stage. Only by observing with an endoscope and taking tissue as needed can the current situation be understood.


On social media, "fear" is conveyed first

WELT's official X posted the headline "First a protective layer is formed, then the cancer risk increases 125 times" as it is. The original article's page also showed many comments, indicating that this figure attracted strong interest.

 

The focus of reactions visible in the public domain is broadly divided into three. The first is anxiety about "I also have heartburn, am I okay?" The second is the question of "Is the 125 times figure about all heartburn patients?" The third is practical interest in "Should I continue taking medication, or can I manage it with lifestyle changes?"

However, individual comments with viewing restrictions cannot be treated as separate public opinions, so it is better to avoid quoting them as if they are real statements. What should be noted instead is the research result that strong relative risk tends to amplify patients' anxiety. Studies targeting Barrett's esophagus patients have shown that even if the actual cancer risk is low, a considerable number experience strong cancer anxiety, to the extent that it affects their awareness of symptoms and quality of life due to overestimating the risk.

What is needed in medical articles is neither to downplay the danger nor to incite fear with only the maximum value. It is to convey "to whom, under what conditions, and to what extent the probability is" simultaneously.


In Japan, the breakdown of "esophageal cancer" differs from that in the West

When reading this topic in Japan, regional differences cannot be overlooked.

According to the National Cancer Center, about 90% of esophageal cancers in Japan are squamous cell carcinomas, and adenocarcinomas account for about 7%. Esophageal adenocarcinoma, which mainly arises from Barrett's esophagus, is of greater importance in the West. On the other hand, squamous cell carcinoma, which accounts for the majority in Japan, is strongly associated with smoking and alcohol consumption, and focusing only on reflux can lose sight of the overall picture of esophageal cancer prevention.

Therefore, the "125 times" figure from the German article cannot be directly applied to the esophageal cancer risk of the entire Japanese population. Nevertheless, this does not justify neglecting reflux symptoms or Barrett's esophagus. For Japanese people, it is necessary to address heartburn while also paying attention to smoking, alcohol consumption, and especially the combination of both.

Moreover, in Japan, there are relatively many opportunities to undergo health checkups and gastric endoscopy. When diagnosed with "Barrett's mucosa," "hiatal hernia," or "reflux esophagitis" during an examination, it is practical to confirm with a doctor about the presence of dysplasia, the length of changes, and the timing of the next observation, rather than being frightened by the words alone.


Measures you can take yourself and the line to connect to medical care

Revising your lifestyle can help improve reflux symptoms. Weight loss in cases of abdominal obesity, quitting smoking, elevating the upper body during sleep, and finishing meals at least three hours before lying down are recommended in public medical information.

Regarding food, it is not a simple matter of "banning coffee, chocolate, and spicy foods for everyone." While some people find that highly acidic foods, alcohol, caffeine, high-fat foods, mint, and spices worsen symptoms, triggers vary greatly among individuals. Recording meals and symptoms and verifying reproducibility yourself is easier to continue than a blanket ban without evidence.

In pharmacotherapy, proton pump inhibitors (PPIs), which suppress gastric acid secretion, are central. PPIs are effective not only in improving symptoms but also in healing esophageal mucosa in many people. However, it is not desirable to continue masking symptoms for a long time with over-the-counter medications or those on hand. It is necessary to confirm the necessity, dosage, duration, and balance with side effects with a doctor or pharmacist.

If you have the following symptoms, do not dismiss them as mere heartburn and consult an internist or gastroenterologist early.

  • Food getting stuck, difficulty swallowing, or pain when swallowing

  • Unintentional weight loss or loss of appetite

  • Vomiting blood, vomit resembling coffee grounds, or black stools

  • Repeated vomiting

  • Persistent heartburn despite over-the-counter medication or lifestyle changes

  • Chest pain, shortness of breath, cold sweat

Particular attention is needed for the last symptom of chest pain. Even if you think it's heartburn, there is a possibility of heart disease. If you experience severe chest pain, difficulty breathing, or cold sweat, do not self-diagnose it as a digestive symptom and consider the urgency.


The severity of pain does not match mucosal changes

The difficulty of reflux disease lies in the fact that the severity of symptoms does not necessarily match the degree of mucosal damage. Some people have severe heartburn but no significant lesions found on endoscopy, while others have Barrett's esophagus with little to no symptoms.

Therefore, it cannot be concluded that "it's okay because it doesn't hurt" or "it's cured because the symptoms disappeared with medication." However, this does not mean that everyone without symptoms should undergo endoscopy. It is important to combine factors such as age, gender, long-term reflux, smoking, abdominal obesity, and family history to determine the necessity of examination with a healthcare provider.

Even if Barrett's esophagus is found, it does not immediately lead to cancer treatment. If there is no dysplasia, endoscopic observation is performed at intervals appropriate to the condition while suppressing gastric acid reflux. If dysplasia is confirmed, endoscopic resection or ablation treatment is considered based on a pathological diagnosis by a specialist. Now, there are options to intervene at the pre-cancerous stage rather than waiting for cancer to develop.


The number to truly remember is not "125"

What should be taken away from this topic is not the fear that experiencing heartburn increases cancer risk by 125 times.

What should be remembered is that long-term reflux can cause changes in the esophageal mucosa. Barrett's esophagus is not cancer, and most people do not develop cancer. Even if the relative risk appears high, it is necessary to confirm the absolute risk and the stage of the lesion. Also, do not ignore warning symptoms such as difficulty swallowing, weight loss, or bleeding.

Heartburn is a common symptom. Therefore, there is no need for everyone to be afraid. However, being common and being dismissible are not the same.

Turning the small signs from the esophagus into a trigger for consultation and prevention, rather than fear, is far more meaningful than knowing the maximum value of "125 times." Knowing how long your symptoms have persisted, what risk factors you have, and what stage you are at based on examinations is much more significant.

※This article provides general medical information and is not a substitute for individual diagnosis or treatment. Please consult a medical institution if you have symptoms.


Source URL

Related Articles